8 Stocks Under $10 Moving Higher
Endocyte
Endocyte (ECYT) is a biopharmaceutical company. Endocyte is engaged in developing therapies for the treatment of cancer and inflammatory diseases. This stock is trading up 12.2% at $5.50 in recent trading.
Today's Range: $4.93-$5.78
52-Week Range: $3.02-$14.80 Volume: 2.2 million Three-Month Average Volume: 867,048 >>7 Cancer Drug Stocks to Know Right Now From a technical perspective, ECYT is ripping higher today off some near-term previous support at $4.83 with monster volume. This move is quickly pushing ECYT within range of triggering a big breakout. That breakout will trigger once ECYT takes out some near-term overhead resistance at $6.48 with volume. Traders should now look for long-biased trades if EYCT can sustain a high-volume move and close over $6.48. Look for volume on that move that's near or well above 867,048 shares. If we get that action soon, then look for ECYT to make a run at its 200-day moving average of $8.68 in the near future.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
